La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Xiaomi a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Xiaomi..

Xiaomi (OTC:XIACF) Azioni, Catena delle Opzioni

Xiaomi is a technology product and services company founded in early 2010, focusing mainly on smartphones and Internet of Things products and related internet services. An early adopter of online smartphone sales, Xiaomi uses Android as its operating system but has its own customized user interface called MIUI. As competition in its home Chinese smartphone market intensified and growth has slowed, it has expanded into other markets and has become the smartphone market leader in India and is gaining market share in Europe. From 2020 to 2024, from a country perspective, around 50% of its overall revenue was generated in mainland China, down from 94% in 2015. The company listed on the Hong Kong market at the beginning of July 2018.

iPhone and Xiaomi Photo by Alan Sau on Shutterstock

News

Tech

AAPL

SSNLF

XIACF

XIACY

Una svolta inattesa potrebbe ridisegnare il settore dell&#39;elettronica. Quali opportunità per gli investitori?

Stampa 3D: chi guida il futuro degli smartphone e delle nuove tecnologie

Emerging Markets

Media

AMZN

BIDU

MSFT

NVDA

Con una strategia ambiziosa nel mercato dei semiconduttori, una nota azienda si prepara a rivoluzionare il settore dell&#39;IA.

Quest&#39;azienda vuole prendere il posto di Nvidia nell&#39;ambito dell&#39;IA

Xiaomi Corp

No gainer in today's Pre-market session. 
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">198.90</td>
<td align="right">-10.63</td>
<td align="right">-5.08</td>
<td>109.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">89.50</td>
<td align="right">-4.63</td>
<td align="right">-4.92</td>
<td>258.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">193.54</td>
<td align="right">-9.77</td>
<td align="right">-4.81</td>
<td>29.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">48.27</td>
<td align="right">-1.89</td>
<td align="right">-3.77</td>
<td>513.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">128.21</td>
<td align="right">-4.84</td>
<td align="right">-3.64</td>
<td>14.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">84.20</td>
<td align="right">-2.81</td>
<td align="right">-3.23</td>
<td>11.9K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">94.00</td>
<td align="right">-2.85</td>
<td align="right">-2.95</td>
<td>28.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">80.35</td>
<td align="right">-1.20</td>
<td align="right">-1.48</td>
<td>337.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">41.53</td>
<td align="right">-0.55</td>
<td align="right">-1.31</td>
<td>1.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">143.30</td>
<td align="right">-1.00</td>
<td align="right">-0.70</td>
<td>17.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">79.17</td>
<td align="right">-0.25</td>
<td align="right">-0.32</td>
<td>134.1K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alert provides traders with a compiled way to read macro-level market trends. Investors garner a particular interest in sector movers to better determine sectors that are over- or under-performing to make better investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Movers

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For April 3, 2025

Barclays analyst Adrienne Yih maintains PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) with a Overweight and raises the price target from $98 to $103.

Price Target

Analyst Ratings

Barclays Maintains Overweight on PVH, Raises Price Target to $103

WIIM

NEGG

Newegg Commerce shares are trading lower after the company announced a 20-for-1 reverse stock split.

LCID

Lucid Group shares are trading lower after the company announced it raised $1 billion via a convertible senior note offering.

RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) announced on Thursday that it has signed a definitive <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44623466/rpm-announces-acquisition-of-the-pink-stuff" rel="noreferrer noopener">agreement to acquire</a> U.K.-based Star Brands Group, the maker of The Pink Stuff, for its Rust-Oleum subsidiary. Financial terms not disclosed.
The Pink Stuff, best known for its standout cleaning paste, has rapidly emerged as a notable household cleaner in the U.S. and beyond. It targets a combined U.S.-Europe market valued at approximately $12 billion, with steady growth projected.
The acquisition will expand RPM&#8217;s Consumer Group by adding a fast-growing, globally recognized cleaning brand known for high-performance products and bold, innovative marketing.
This deal further strengthens Rust-Oleum&#8217;s cleaners portfolio, which has grown through strategic acquisitions and product innovations. With estimated 2024 sales of around £150 million, The Pink Stuff enhances RPM&#8217;s presence across key channels, including retail and e-commerce. The transaction is expected to close late in&nbsp;the fourth quarter&nbsp;of fiscal 2025 or early in the&nbsp;first quarter&nbsp;of fiscal 2026, with Star Brands&#8217; leadership team remaining in place to drive continued growth in partnership with Rust-Oleum.
&#8220;This acquisition aligns with Rust-Oleum&#8217;s vision to drive growth through leading consumer brands known for providing effective solutions in attractive end markets,&#8221; said RPM Chairman and CEO Frank C. Sullivan. &#8220;The Pink Stuff will strengthen our presence and scale in multiple sales channels, and, thanks to improvements we have made through our MAP 2025 program, we are well-positioned to support the brand&#8217;s growth globally.&#8221;
As of November 30, 2024, RPM held cash and cash equivalents of <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42839743/rpm-reports-record-fiscal-2025-second-quarter-results" rel="noreferrer noopener">$268.68 million</a>.
Price Action: RPM shares closed 0.97% higher at $117.58 on Wednesday.
Photo via Shutterstock.

Equities

RPM Snaps Up The Pink Stuff Maker To Supercharge Global Cleaning Game

Contracts

ATPC

AGAPE ATP Announced Subsidiary ATPC Green Energy Entered Into Two Sales And Purchase Agreements Worth Approximately $24B With Swiss One Oil & Gas

Willdan Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLDN#NASDAQ">WLDN</a>) announced today that it has been awarded a $30 million energy savings performance contract to expand energy and infrastructure modernization services for the City of Fairfield's critical facilities. These projects will enhance efficiency, sustainability, and operational performance through upgrades including on-site solar photovoltaic energy generation, electric vehicle charging infrastructure, and central plant renovations.
"These upgrades to City Hall, our police department, and other critical facilities will increase efficiency and resiliency while reducing climate impacts and generating long-term cost savings for our community," said Marisa Cumpian, the City of Fairfield's Sr. Management Analyst. "As the City continues to grow, we appreciate Willdan's ongoing support in improving quality of life for our residents."
Willdan has supported the City of Fairfield for over 25 years with engineering, special district and federal compliance financial services, and electrification strategies for their transit and municipal fleets.

WLDN

Willdan Receives $30M Contract To Expand Energy And Infrastructure Modernization Services For The City Of Fairfield

In September, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) Caremark, Cigna Corp&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) Express Scripts, and UnitedHealth Group Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) Optum—for allegedly engaging in unfair and anti-competitive practices that have inflated the list <a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">price of insulin medications</a>.
The&nbsp;complaint&nbsp;accuses the PBMs of creating a system that benefits them financially by prioritizing drug rebates, forcing patients to pay higher costs for life-saving insulin. These PBMs, referred to as the Big Three, administer around 80% of <a target="_blank" href="https://www.benzinga.com/news/large-cap/24/09/40964870/us-federal-trade-commission-sues-cvs-health-cigna-unitedhealths-pharmacy-benefit-managers-for-infl" rel="noreferrer noopener">prescriptions in the U.S</a>.
The FTC is now pausing after the agency submitted <a href="https://www.ftc.gov/system/files/ftc_gov/pdf/d9437_2025.04.01_commorderstayingadjudication.pdf" target="_blank" rel="noreferrer noopener">an order</a> seeking an administrative stay in the case.
Also Read:<a target="_blank" href="https://www.benzinga.com/government/regulations/25/01/43010888/ftc-says-unitedhealth-cvs-cigna-make-billions-via-pbms-on-specialty-drugs" rel="noreferrer noopener"> FTC Says UnitedHealth, CVS, Cigna Make Billions Via PBMs On Specialty Drugs</a>
The agency does not cite any sitting commissioners who can join the proceedings. The two sitting commissioners, Republicans Andrew Ferguson and Melissa Holyoak, <a href="https://www.benzinga.com/government/24/10/41172976/texas-attorney-general-sues-insulin-manufacturers-and-pharmacy-benefit-managers-over-price-fixing-co" target="_blank" rel="noreferrer noopener">have recused themselves</a>.
According to the order filed this week, the stay will remain in place for at least 105 days. The courts also set an evidentiary hearing for 225 days after the stay lifts.
Reuters notes that of its five sitting commissioners, two were fired, two were removed from the case, and one resigned when Trump took office.
Several state and local governments also filed lawsuits against drug companies and pharmacy benefit managers, accusing them <a target="_blank" href="https://www.benzinga.com/markets/equities/24/08/40560002/governments-suing-pharmacy-benefit-managers-over-insulin-prices-have-long-benefited-from-their-r" rel="noreferrer noopener">of inflating insulin prices</a>.
In November 2024, the FTC faced legal challenges from three competing pharmacy-benefit managers over its attempt to restrict their ability to negotiate drug prices for&nbsp;<a target="_blank" href="https://www.benzinga.com/general/health-care/24/11/42097386/cvs-healthcignaunitedhealths-pharmacy-benefit-managers-accuse-ftc-of-overreach-in-effort-to-reshape-drug-rebate-system" rel="noreferrer noopener">health plan sponsors</a>.
The PBMs argue that this action seeks to upend current drug rebate contracts and disrupt long-standing practices, all while expanding the FTC&#8217;s authority beyond traditional limits.
The companies also&nbsp;contend&nbsp;that the administrative proceeding violates constitutional principles by lacking independent judicial oversight and claim that the FTC&#8217;s approach could result in significant and irreparable injury.
Price Action: CI stock is down 1.13% at $328.16, UNH stock is up 0.04% at $523.40, and CVS stock is down 0.85% at $67.49&nbsp;during the premarket session at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44614073/sportradars-big-bet-on-sports-data-analyst-raises-2026-forecast-sees-major-growth-in-live-betting" target="_blank" rel="noreferrer noopener">Sportradar&#8217;s Bets Big On Sports Data, Analyst Says Company Has Favorable Setup</a></li>
</ul>
Image: Shutterstock

Large Cap

Health Care

Legal

General

FTC Pauses Lawsuit Against CVS, Cigna, UnitedHealth's PBMs Amid Commissioner Shortage

Lucid Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) shares are trading lower Thursday after the company priced a convertible senior notes offering. Lucid also provided a production and deliveries update for the first quarter. Here&#8217;s what <a href="https://www.benzinga.com/pressreleases/25/04/n44621027/lucid-group-inc-prices-1-000-000-000-convertible-senior-notes-offering">you need to know</a>.
What To Know: Lucid announced that it <a href="https://www.benzinga.com/pressreleases/25/04/n44614912/lucid-announces-q1-production-deliveries-sets-date-for-first-quarter-2025-results">produced</a> 2,212 vehicles and delivered 3,109 in the first quarter. The company noted that it has an additional 600 vehicles in transit to Saudi Arabia for final assembly. 
The weakness in shares comes after the company announced plans to offer $1 billion of convertible senior notes due 2030 in a private offering to institutional investors. Lucid also granted the initial purchasers of the notes a 13-day period to buy up to an additional $100 million of the notes. 
The sale of the convertible senior notes is expected to settle on or about April 8. Lucid anticipates net proceeds of approximately $983.6 million. The company expects to use the proceeds to fund repurchases of its outstanding 1.25% convertible senior notes due 2026. 
Lucid also scheduled its first-quarter financial results for after the market close on May 6. Analysts currently expect the company to report a loss of 26 cents per share and revenue of $238.36 million, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
It&#8217;s worth noting that broader markets are facing heavy selling pressure on Thursday after the Trump administration announced <a href="https://www.benzinga.com/markets/25/04/44621408/market-access-has-a-price-trump-unveils-list-of-tariffs-countries-targeted">reciprocal tariffs</a> on several countries around the world. The announcement came just after the market close on Wednesday, sparking a major selloff after hours. The weakness has continued into Thursday morning. 
See Also: <a href="https://www.benzinga.com/25/04/44623918/global-markets-rattle-under-tariff-shock-asia-sinks-europe-tumbles-dollar-weakens-oil-tanks-global-markets-today-while-us-slept">Global Markets Rattle With Trump&#8217;s Tariff, Dollar Weakens, Oil Tanks &#8211; Global Markets Today While US Slept</a>
LCID Price Action: <a href="http://benzinga.com/quote/lcid">Lucid shares</a> were down 9.37% at $2.18 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: courtesy of Lucid.

Offerings

Lucid Stock Is Hitting The Brakes Thursday: What's Driving The Action?

Management

FBIN

Fortune Brands Appoints Jonathan Baksht Executive Vice President And CFO, Effective May 5, 2025

GEVO

Gevo's Verity Partners With Minnesota Soybean Processors To Track And Verify Sustainable Agriculture Attributes

JP Morgan analyst Kian Abouhossein maintains Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) with a Neutral and lowers the price target from $129 to $125.

JP Morgan Maintains Neutral on Morgan Stanley, Lowers Price Target to $125

PALO ALTO, CA, April 03, 2025 (GLOBE NEWSWIRE) -- Cloudastructure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSAI#NASDAQ">CSAI</a>) ("Cloudastructure" or the "Company") today announced it has partnered with one of the nation's leading real estate investment firms—managing billions in commercial and residential assets—to expand the firm's commitment to AI-driven security. This initiative marks an expansion of an existing relationship between the two companies, building upon prior successful deployments to now include Cloudastructure's advanced surveillance and remote guarding solutions across seven multifamily communities, with additional rollouts planned in the near future.
Managing thousands of residential units across the country, the firm remains committed to safeguarding its assets while elevating the resident experience. After a series of security incidents—including trespassing and vehicle break-ins—the firm began searching for a proactive, scalable solution that could not only deter crime in real time but also enhance operational efficiency.
Cloudastructure's AI-driven platform delivers:
<ul>
<li>Cloud-based advanced AI analytics</li>
<li>Seamless remote guarding software</li>
<li>24/7 live monitoring</li>
</ul>
With crime deterrence rates exceeding 97% (based on internal data from 2023 to date), Cloudastructure's technology provides a cost-effective alternative to traditional security models, enhancing asset protection while reducing liability risks.
"The platform has already proven its value at several of the firm's Atlanta properties," a company manager stated, "Our experience at our Atlanta assets has been overwhelmingly positive, and we look forward to continued expansion of the platform into other markets."
This latest contract represents a significant milestone in the firm's ongoing investment in next-generation security solutions, transforming security from a traditional cost center into a strategic value driver. A September 2024 survey by the National Apartment Association underscores the impact of this approach: while only 13% of multifamily residents participating in the survey currently live in a community with monitored cameras, 70% of those residents believe these systems actively prevent crime. Furthermore, they were 17% more likely to recommend a monitored community to a friend.
"This partnership reflects a forward-thinking approach to risk management and asset optimization, both for property owners and their investors," said James McCormick, CEO of Cloudastructure. "As the multifamily sector continues to evolve, AI-powered security is no longer a luxury—it is a strategic investment that drives operational efficiency, enhances resident satisfaction, and ultimately contributes to long-term portfolio value. We are happy to be expanding our successful relationship with this valued client and look forward to supporting their vision and helping them scale that success across new markets."

CSAI

Cloudastructure Enters AI Security Partnership With Leading Real Estate Investment Firm Across Multifamily Communities

Shares of Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) fell 5.3% to $39.63 Thursday morning as President Donald Trump's sweeping reciprocal tariffs rattled financial markets and <a href="https://www.benzinga.com/markets/25/04/44621408/market-access-has-a-price-trump-unveils-list-of-tariffs-countries-targeted">heightened fears</a> of a global economic downturn.
The second-largest U.S. bank by assets is particularly vulnerable to the escalating trade tensions, as <a href="https://www.benzinga.com/25/04/44624245/tariffs-to-plug-the-hole-for-income-tax-cuts-to-come-economists-predict-what-more-could-be-expected">rising tariffs</a> threaten economic growth, corporate lending and consumer spending—all key revenue drivers for the bank.
What To Know: Bank of America, which generates significant revenue from interest income on loans and mortgages, faces mounting concerns that the tariffs could stoke inflation while <a href="https://www.benzinga.com/markets/25/04/44623179/larry-summers-warns-trumps-tariffs-will-deliver-oil-crisis-like-shock-slash-30-trillion-from-economy-as-markets-plunge">slowing economic activity</a>. Additionally, if businesses cut back on expansion due to trade uncertainty, demand for corporate credit could weaken.
Also, Bank of America's investment banking division, which earns fees from mergers, acquisitions and capital markets activity, may suffer if market volatility persists. Global trade disruptions could deter companies from pursuing major deals, further pressuring the bank's fee-based income.
Read Also: <a href="https://www.benzinga.com/general/market-summary/25/04/44623604/us-stock-likely-to-open-lower-following-trumps-tariffs-worse-than-the-worst-case-scenario-says-analyst">US Stocks Likely To Open Lower Following Trump&#8217;s Tariffs: &#8216;Worse Than The Worst Case Scenario,&#8217; Says Analyst</a>
<h2 class="wp-block-heading">How To Buy BAC Stock</h2>
By now you're likely curious about how to participate in the market for Bank of America &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Bank of America, which is trading at $41.85 as of publishing time, $100 would buy you 2.39 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, BAC has a 52-week high of $48.08 and a 52-week low of $34.15.

What's Going On With Bank Of America (BAC) Shares

JP Morgan analyst Kian Abouhossein maintains Goldman Sachs Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) with a Overweight and lowers the price target from $625 to $614.

JP Morgan Maintains Overweight on Goldman Sachs Group, Lowers Price Target to $614

SOUTH SAN FRANCISCO, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTI#NASDAQ">SNTI</a>) ("Senti Bio" or the "Company"), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that three abstracts have been selected for an oral minisymposium and poster presentations at the <a href="https://www.globenewswire.com/Tracker?data=0d6FDDS7V7yE7A3brrle3XLDGZUiCYJJR3VHPVQvSTC8-Tkf3B6VQ5MmccHOA03HYqiDC8IO_QazUzAq7KjzuoLYNQ0W2AePXDs3ByBHsva-Gi2fZ87GUH5R-C9-BwyQ7s_ZgjSg4UKMRxvpoJfsCR1MNvhe34k_dMTHTGq5_pd7TPE0QV8L2W-pEwBeUk6L4Vgi3-OGcbW5ZjTmVIDhZA==">American Association for Cancer Research (AACR) Annual Meeting 2025</a>, taking place April 25-30, 2025, at the McCormick Place Convention Center in Chicago, IL.
Kanya Rajangam, MD, PhD, President, Head of R&amp;D and Chief Medical Officer of Senti Bio commented, "We are excited to present updated clinical and correlative data from our ongoing SENTI-202 trial, along with detailed preclinical characterization of our Logic Gate technology. The preclinical data shows the EMCN inhibitory CAR (our NOT gate) protects healthy bone marrow cells from on-target off-tumor toxicity in vivo. Taken together, this data continues to support our enthusiasm for the potential of SENTI-202 to treat r/r AML and for Logic Gating, including our unique NOT gates, to be broadly applied to oncology to enhance the selective targeting of cancer while sparing healthy cells that may express the same targets."

Biotech

SNTI

Senti Bio To Release SENTI-202 Clinical Data And Novel Logic Gated Gene Circuit Mechanism Of Action In Oral And Poster Presentations At The American Association For Cancer Research Annual Meeting In Chicago April 25-30, 2025

Genius Group shares are trading lower after the company announced it has been forced to sell its bitcoin treasury after being blocked from selling shares or raising funds.

DWTX

Dogwood Therapeutics Regains Nasdaq Compliance

<ul>
<li>$3.1 million of new orders received during the current calendar year</li>
<li>$6.6 million customer program backlog expected to be delivered over next 12 months
<ul>
<li>$3.9 million of additional commitments expected to be received for calendar 2026 &nbsp;</li>
</ul>
</li>
</ul>

POCI

Precision Optics Enters Into Main Purchase Agreement With Aerospace Customer And Expands Program Backlog To $6.6M

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.tetratech.com%2F&amp;esheet=54232779&amp;newsitemid=20250402878397&amp;lan=en-US&amp;anchor=Tetra+Tech%2C+Inc.&amp;index=1&amp;md5=ae1f8ff4fae8cfc0c2154ab4bc420765">Tetra Tech, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NASDAQ">TTEK</a>), a leading provider of high-end consulting and engineering services in water, environment, and sustainable infrastructure, announced today that the U.S. Army Corps of Engineers (USACE) Los Angeles District awarded the Company a multiple-award contract not to exceed $46 million.
Under the 3-year contract, Tetra Tech will provide comprehensive engineering and design services to support a wide range of essential projects, including civil and military infrastructure, coastal and port facility development and improvements, dam and levee safety assessments and improvements, inland flood control design and implementation, and emergency operations support for flood and earthquake response activities.
"Tetra Tech is pleased to continue our long history of delivering innovative and sustainable engineering solutions for the USACE Los Angeles District," said Dan Batrack, Tetra Tech Chairman and CEO. "Our technical leadership and experience addressing complex engineering challenges position us to deliver exceptional value to our client and its stakeholders

Comments

Xiaomi

Xiaomi (XIACF) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO